// App-Quantinova.ai

Tu1040 AASLD : Evaluation of Phlebotomy As a Therapy for Non-Alcoholic Fatty Liver Disease

Researchers

Presenter

  • Paul C. Adams

Principal Investigators

  • Subrata Chakrabarti

Medical Centers

  • University of Western Ontario, London, ON, Canada

  • Gastroenterology, University of Western Ontario, London, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Fatty Liver Disease

  • Nonalcoholic steatohepatitis

Biomarkers

  • Alanine transaminase

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved